Medirom Healthcare Technologies Inc Stock Price, News & Analysis

MEDIROM Healthcare Technologies (NASDAQ: MRM) announces significant milestones for its healthcare app 'Lav', with over 100 contracted companies and 10,000 supported individuals for specific health guidance services. The app, launched in 2019, has facilitated a total weight loss of 15,421 kg among users. Lav serves approximately 1 in 14 health insurance associations in Japan, offering personalized health coaching through chat features, activity tracking, and lifestyle management tools. The app supports Japan's Specific Health Guidance Program, targeting medical insurance subscribers aged 40-74 to prevent lifestyle-related diseases. Users can track weight, steps, sleep, and meals while receiving professional coaching support. The service has received positive evaluations and continues to expand its presence in Japan's healthcare technology sector.

MEDIROM Healthcare Technologies (MRM) reported strong financial results for 2024, with total revenue increasing 22% to $52.7M, up from $43.4M in 2023. Net income improved 20% to $878,000 ($0.17 per share) compared to $731,000 ($0.15 per share) in 2023. The growth was primarily driven by a 23% increase in the Relaxation Salon Segment revenue to $47.3M. The company's cost management improved, with cost of revenues decreasing to 72.9% from 77.0% and SG&A expenses dropping to 27.0% from 28.7%. Cash position strengthened to $2.1M, though total debt increased to $11.9M. In early 2025, MEDIROM completed a $5M ADS offering and secured a $2.4M bank loan. The company aims to expand its Digital Preventative Healthcare business and increase Lav® users through strategic initiatives.

MEDIROM Healthcare Technologies (Nasdaq: MRM) has scheduled a webcast for May 21, 2025, at 8:30 AM ET to discuss its financial results for fiscal year 2024. The company will release its financial results after market close on May 20, 2025. MEDIROM, a Japanese holistic healthcare company, operates 307 relaxation salons under the Re.Ra.Ku® brand and offers various healthcare services. The company has expanded into health tech with its on-demand training app "Lav®", developed the "MOTHER Bracelet®" smart tracker, and launched REMONY, a remote monitoring system for corporate clients. The webcast will be accessible via dial-in numbers for North America, International, and Japan participants, with a replay available until June 4, 2025.

MEDIROM Healthcare Technologies (Nasdaq CM: MRM) has secured a new unsecured short-term bank loan of JPY350 million (approximately $2.4 million) with a 1.875% annual interest rate. JPY200 million of the loan funds will be used to repay the indebtedness of MEDIROM Mother Labs Inc., a subsidiary and loan guarantor.

The remaining funds will support general working capital, including the development of Mother Bracelet. CEO Koji Eguchi stated that this financing strengthens their financial position and provides additional support for the Mother Bracelet development.

MEDIROM Healthcare Technologies (NASDAQ: MRM) announced that Yasuhiro Hayami, Chief Business Officer of MEDIROM Mother Labs, has made a second investment in Mother Labs' Series A financing. The investment values Mother Labs at a pre-money valuation of JPY9 billion (approximately US$60 million) as of March 13, 2025.

This follow-up investment comes after Mr. Hayami's initial Series A investment in December 2024. As a committed senior executive, Hayami shares MEDIROM's corporate philosophy, vision, and commitment to future growth potential. His background includes founding INIT Co., in 1996, serving as Executive Officer at transcosmos inc. in 2004, and founding Wise, Inc. in 2014. In 2024, he was appointed Chairman of MEDIROM Rehab Solutions and Chief Business Officer of MEDIROM Mother Labs.

MEDIROM Healthcare Technologies (Nasdaq: MRM) released preliminary, unaudited financial results for FY2024 under Japanese GAAP. The company reported total revenue of JPY8.2 billion ($52.6 million), a JPY1.4 billion increase from 2023, driven by salon sales to investors, increased store outsourcing revenue, and revenue from their newly acquired rehabilitation business.

The company's adjusted operating income reached JPY160 million ($1.0 million), marking a significant improvement from the previous year's operating loss. Key performance indicators showed 308 total salons as of December 2024, serving 945,395 customers with an average sales per customer of JPY7,111 ($45.2) and a repeat ratio of 76.3%.

These results exclude approximately JPY140 million in offering-related expenses from their second public equity offering in December 2024. The company notes these preliminary results are subject to final audit under U.S. GAAP standards.

MEDIROM Healthcare Technologies Inc. (MRM) has released its December 2024 Key Performance Indicators. The company reported 80,764 total customers served with sales per customer of JPY 7,384, showing an increase from JPY 7,271 in December 2023. The customer repeat ratio stood at 77.6% with an operation ratio of 45.9%.

The company's salon network comprised 308 locations with 283 providing comparable data. In their Health Tech Business segment featuring the Lav® app, MEDIROM has expanded its presence in the specific health guidance program market, reaching 97 corporate insurance association contracts and 8,816 cumulative users by December 2024.

MEDIROM Healthcare Technologies (NASDAQ: MRM) has completed all corporate capital registration procedures for its offering of 2,860,000 common shares represented by American Depositary Shares. The offering, which closed on December 11, 2024, generated gross proceeds of approximately $5 million.

Following the registration completion on January 14, 2025, the company's registered corporate capital and capital reserve amounts are 365,019,146 yen and 365,019,145 yen respectively, with 7,994,451 total outstanding shares. This marks the first follow-on registered underwritten public offering in the United States by a Japanese company listed solely on a U.S. stock exchange.

The proceeds will be used for working capital and general corporate purposes, including potential investments, acquisitions, strategic collaborations to expand customer base, and development and marketing of new services.

MEDIROM Healthcare Technologies (NASDAQ: MRM) announces that its subsidiary, MEDIROM MOTHER Labs, is providing its remote health monitoring system, REMONY, and charging-free smart tracker device, MOTHER Bracelet, to TOPPAN's Electronics Division.

The MOTHER Bracelet is promoted as the world's first 24/7 recharge-free smart tracker, powered by temperature difference between body and air. It tracks five health metrics: heart rate, surface body temperature, step count, sleep, and calories burned. The REMONY system combines this bracelet with a gateway for automatic data synchronization and real-time management.

TOPPAN will implement this technology to monitor employee health, particularly focusing on workers living alone or on solo assignments, aiming for early detection and response to health abnormalities. This implementation aligns with TOPPAN's initiatives to ensure employee physical and mental well-being.